1. Kafol, Jan, Gnidovec Strazisar, Barbara, Drole Torkar, Ana, Debeljak, Maruša, Groselj, Urh. 2024. VIPAS39 related arthrogryposis-renal dysfunction-cholestasis syndrome-case report and systematic review. In Orphanet journal of rare diseases, 19, 496. doi:10.1186/s13023-024-03486-2. https://pubmed.ncbi.nlm.nih.gov/39736737/
2. Rosoff, Daniel B, Wagner, Josephin, Bell, Andrew S, Jung, Jeesun, Lohoff, Falk W. 2024. A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinking. In Nature human behaviour, 9, 188-207. doi:10.1038/s41562-024-02040-1. https://pubmed.ncbi.nlm.nih.gov/39528761/
3. Aflatounian, Majid, Smith, Holly, Farahani, Fatemeh, Gissen, Paul, Rezaei, Nima. 2016. Novel VIPAS39 mutation in a syndromic patient with arthrogryposis, renal tubular dysfunction and intrahepatic cholestasis. In European journal of medical genetics, 59, 237-9. doi:10.1016/j.ejmg.2016.01.005. https://pubmed.ncbi.nlm.nih.gov/26808426/
4. Li, Qinghong, Sun, Yue, van IJzendoorn, Sven C D. 2021. A Link between Intrahepatic Cholestasis and Genetic Variations in Intracellular Trafficking Regulators. In Biology, 10, . doi:10.3390/biology10020119. https://pubmed.ncbi.nlm.nih.gov/33557414/
5. Linhares, Natália Duarte, Fagundes, Eleonora Druve Tavares, Ferreira, Alexandre Rodrigues, da Silva, Luiz Roberto, Pena, Sergio D J. 2022. Mild Phenotype of Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome 1 Caused by a Novel VPS33B Variant. In Frontiers in genetics, 13, 796759. doi:10.3389/fgene.2022.796759. https://pubmed.ncbi.nlm.nih.gov/35281816/
6. Nurden, Alan T, Nurden, Paquita. 2016. Should any genetic defect affecting α-granules in platelets be classified as gray platelet syndrome? In American journal of hematology, 91, 714-8. doi:10.1002/ajh.24359. https://pubmed.ncbi.nlm.nih.gov/26971401/
智鼠故事 
